Trium Capital’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
Other funds holding MYOV
Trium Capital's MYOV Position: Q1 2023 in Review
Trium Capital sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 109,482 shares — an estimated $2.95M sold.
Trium Capital first reported a position in MYOV in Q4 2022 and held it in 1 quarter. The position peaked at $2.95M in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.
- Trium Capital reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
- Trium Capital sold 109,482 Myovant Sciences Ltd. shares in Q1 2023, an estimated $2.95M.
- Trium Capital first reported a position in Myovant Sciences Ltd. in Q4 2022 and held it in 1 quarter.
- Trium Capital's Myovant Sciences Ltd. position peaked at $2.95M in Q4 2022.
- 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.
Based on Trium Capital's 13F filing for Q1 2023, filed 16 May 2023.